Oral, nasal and pulmonary dosage formualtions of copolymer 1

Details Oral, nasal and pulmonary dosage formualtions of copolymer 1 Oral, nasal and pulmonary dosage formualtions of copolymer 1

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 9/28 (2006.01) A61K 9/48 (2006.01) A61K 31/785 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2400374

Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose are disclosed. Processes for the manufacture of such compositions are also disclosed.

L'invention concerne des compositions pharmaceutiques utiles pour le traitement des maladies auto-immunes chez les mammifères. Ces compositions comprennent en tant que principe actif une quantité efficace sur le plan pharmaceutique du copolymère 1. L'invention concerne également de la cellulose microcristalline ainsi que des processus de préparation desdites compositions.

Affiliated with

Also associated with

Rating

Oral, nasal and pulmonary dosage formualtions of copolymer 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral, nasal and pulmonary dosage formualtions of copolymer 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral, nasal and pulmonary dosage formualtions of copolymer 1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1962154